| 今开：3.25 | 昨收：3.49 |
| 最高：3.25 | 最低：3.25 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.2798674E7 |
美股滚雪球2023-07-19 09:17
Neurogene宣布和$Neoleukin医疗(NLTX)$ 以全股票的形式进行合并。
合并后的公司将专注于推进Neurogene的差异化遗传药物系列，包括治疗Rett综合征的临床阶段产品NGN-401，该产品使用新型基因调控技术，具有潜在的同类最佳水平。
合并后的公司预计将以Neurogene的名义运营，并在纳斯达克以“...查看全文
Neoleukin医疗(NLTX)2023-12-07 05:35
$Neoleukin医疗(NLTX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-23-289925 Act: 34 Size: 66 KB 网页链接查看全文
Neoleukin医疗(NLTX)2023-12-05 06:15
$Neoleukin医疗(NLTX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-23-288502 Act: 34 Size: 342 KB 网页链接查看全文
Neoleukin医疗(NLTX)2023-12-01 05:15
$Neoleukin医疗(NLTX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-23-286269 Act: 34 Size: 33 KB 网页链接查看全文
Neoleukin医疗(NLTX)2023-12-05 06:25
$Neoleukin医疗(NLTX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-23-288509 Act: 34 Size: 172 KB 网页链接查看全文
Neoleukin医疗(NLTX)2023-12-07 05:25
$Neoleukin医疗(NLTX)$ 8-K Current report, item 8.01 Accession Number: 0001193125-23-289922 Act: 34 Size: 212 KB 网页链接查看全文
Neoleukin医疗(NLTX)2023-11-15 00:35
$Neoleukin医疗(NLTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-038797 Act: 34 Size: 4 MB 网页链接查看全文
Neoleukin医疗(NLTX)2023-11-14 19:15
$Neoleukin医疗(NLTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003297 Act: 33 Size: 1 KB 网页链接查看全文
Neoleukin医疗(NLTX)2023-11-09 03:45
$Neoleukin医疗(NLTX)$ S-4/A [Amend] Registration of securities, business combinations Accession Number: 0001193125-23-273390 Act: 33 Size: 20 MB 网页链接查看全文
Neoleukin医疗(NLTX)2023-10-19 04:15
$Neoleukin医疗(NLTX)$ S-4/A [Amend] Registration of securities, business combinations Accession Number: 0001193125-23-258478 Act: 33 Size: 18 MB 网页链接查看全文
$Neoleukin医疗(NLTX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-23-289925 Act: 34 Size: 66 KB 网页链接
$Neoleukin医疗(NLTX)$ 8-K Current report, item 8.01 Accession Number: 0001193125-23-289922 Act: 34 Size: 212 KB 网页链接
$Neoleukin医疗(NLTX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-23-288509 Act: 34 Size: 172 KB 网页链接
$Neoleukin医疗(NLTX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-23-288502 Act: 34 Size: 342 KB 网页链接
$Neoleukin医疗(NLTX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-23-286269 Act: 34 Size: 33 KB 网页链接
$Neoleukin医疗(NLTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-038797 Act: 34 Size: 4 MB 网页链接
$Neoleukin医疗(NLTX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003297 Act: 33 Size: 1 KB 网页链接
$Neoleukin医疗(NLTX)$ S-4/A [Amend] Registration of securities, business combinations Accession Number: 0001193125-23-273390 Act: 33 Size: 20 MB 网页链接
$Neoleukin医疗(NLTX)$ S-4/A [Amend] Registration of securities, business combinations Accession Number: 0001193125-23-258478 Act: 33 Size: 18 MB 网页链接
$Neoleukin医疗(NLTX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-108324 Act: 34 Size: 85 KB 网页链接